CXDC [China XD Plastics Co] 8-K: China XD Plastics Announces Third Quarter 2010 Results

[China XD Plastics Announces Third Quarter 2010 Results · Revenue grew 80.5% to $65.3 million · * Adjusted net income HARBIN, China, November 1 1 , 2010 Third Quarter 2010 Highlights · Revenue was a record $65.3 million, an increase of 80.5% from the third quarter of 2009 · Gross profit was $16.3 million, an increase of 93.3% from the] [Conference Call Transcript 3Q10 Results China XD Plastics th November 12 Operator: Welcome to the China XD Plastics 3Q10 financial results conference call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, there will be a Q&A session. As a reminder, this conference is being recorded and will be replayed shortly after the call I] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): November 11 CHINA XD PLASTICS COMPANY LIMITED Nevada 001-34546 04-3836208 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) No. 9 Dalian North Road, Haping Road Centralized Industrial Park, Harbin Development Zone, Heilongjiang Province, PRC 150060 (86) 451-8434-6600 Not applicable (Former name or former]

By | 2016-03-25T17:43:03+00:00 November 16th, 2010|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments

SORL [SORL Auto Parts] 8-K: SORL Auto Parts Reports Third Quarter 2010 Financial

[SORL Auto Parts Reports Third Quarter 2010 Financial Results ZHEJIANG, China, November 15, 2010 -- SORL Auto Parts, Inc. (Nasdaq: SORL) On August 31, 2010, the Company, through its subsidiary, acquired automotive parts segments of Ruili Group Co., Ltd. SORL Q3 2010 results were inclusive of Ruili Group’s September results. To facilitate comparability of figures between periods presented, SORL Consolidated] []

By | 2016-03-26T23:18:27+00:00 November 16th, 2010|Categories: Chinese Stocks, SORL, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[NEWS RELEASEystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 -mpany reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million - XIAN, CHINA November 16, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Third Quarter 2010 Highlights Revenuereases 45% YoY to record $18.5 million]

By | 2016-02-05T03:52:45+00:00 November 16th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

CNET [ChinaNet Onlines,] 8-K: (Original Filing)

[ChinaNet Onlines Reports Third Quarter 2010 Earnings;Adjusted Netome grew 100% to $3.9 Million withjusted Diluted EPS of $0.19 Revenuesreased 9.5% in the third quarter, driven by 50.3%rease in Internetvertising and 48.6% reduction in lower margin TVles Gross margins expanded by 1460 bps year-over-year to 65.0%]

By | 2016-02-08T12:51:15+00:00 November 16th, 2010|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Announces Record Organic Revenues of

[NEWS RELEASEystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 -mpany reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million - XIAN, CHINA November 16, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), Third Quarter 2010 Highlights Revenuereases 45% YoY to record $18.5 million]

By | 2016-02-05T03:53:35+00:00 November 16th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

CNET [ChinaNet Onlines,] 8-K: ChinaNet Onlines Reports Third Quarter 2010 Earnings;Adjusted Netome

[ChinaNet Onlines Reports Third Quarter 2010 Earnings;Adjusted Netome grew 100% to $3.9 Million withjusted Diluted EPS of $0.19 Revenuesreased 9.5% in the third quarter, driven by 50.3%rease in Internetvertising and 48.6% reduction in lower margin TVles Gross margins expanded by 1460 bps year-over-year to 65.0%]

By | 2016-02-08T12:51:51+00:00 November 16th, 2010|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 8-K: (Original Filing)

[Gulf Resources, Inc. David Wang, VP of Finance gfre.2008@vip.163.com Email: Helen Xu beishengrong@vip.163.com Email: http://www.gulfresourcesinc.cn/ Web: CCG Investor Relations Mr. Crocker Coulson, President Phone: +1-646-213-1915 crocker.coulson@ccgir.com Email: http://www.ccgirasia.com/ Website: Gulf Resources Reports Third Quarter 2010 Results New York & Shandong Province, November 16, 2010 Third Quarter 2010 Highlights · Revenue was $44.8 million for the three months ended September 30,] [+86 (536) 567 0008 o o o o Item 2.02 Results of Operations and Financial Condition 99.1 Press Release of Gulf Resources, Inc. dated November 15, 2010.]

By | 2016-03-18T09:09:03+00:00 November 16th, 2010|Categories: Chinese Stocks, GURE, SEC Original|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 8-K: Gulf Resources, Inc. David Wang, VP of Finance

[Gulf Resources, Inc. David Wang, VP of Finance gfre.2008@vip.163.com Email: Helen Xu beishengrong@vip.163.com Email: http://www.gulfresourcesinc.cn/ Web: CCG Investor Relations Mr. Crocker Coulson, President Phone: +1-646-213-1915 crocker.coulson@ccgir.com Email: http://www.ccgirasia.com/ Website: Gulf Resources Reports Third Quarter 2010 Results New York & Shandong Province, November 16, 2010 Third Quarter 2010 Highlights · Revenue was $44.8 million for the three months ended September 30,] [+86 (536) 567 0008 o o o o Item 2.02 Results of Operations and Financial Condition 99.1 Press Release of Gulf Resources, Inc. dated November 15, 2010.]

By | 2016-03-18T09:10:56+00:00 November 16th, 2010|Categories: Chinese Stocks, GURE, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. REPORTS THIRD QUARTER REVENUE INCREASE OF 29.7% TO $20.2 MILLION XIANYANG, China, November 15, 2010 (Xinhua-PRNewswire-FirstCall) , - Q3 2010 revenue increased 29.7% to $20.2 million - Q3 2010 Non-GAAP adjusted net income increased 11.9% to $3.5 million with Non-GAAP adjusted EPS of $0.13 - Cash and cash equivalents totaled $16.6 million at September 30 - $8.7]

By | 2016-03-03T13:40:10+00:00 November 15th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. REPORTS THIRD QUARTER REVENUE INCREASE

[BIOSTAR PHARMACEUTICALS, INC. REPORTS THIRD QUARTER REVENUE INCREASE OF 29.7% TO $20.2 MILLION XIANYANG, China, November 15, 2010 (Xinhua-PRNewswire-FirstCall) , - Q3 2010 revenue increased 29.7% to $20.2 million - Q3 2010 Non-GAAP adjusted net income increased 11.9% to $3.5 million with Non-GAAP adjusted EPS of $0.13 - Cash and cash equivalents totaled $16.6 million at September 30 - $8.7]

By | 2016-03-03T13:42:24+00:00 November 15th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar